Search Results

Intrathecal methotrexate, central nervous system toxicity, and response to N-methyl-D-aspartate antagonism: An adult case series.

• Authors : Donaghy, Ryan¹ (AUTHOR) ; Singer, Lauren² (AUTHOR); Dixit, Karan¹ (AUTHOR)

Subjects: *MAGNETIC resonance imaging; *CENTRAL nervous system; *WHITE matter (Nerve tissue)

• Source: Neuro-Oncology Practice. Oct2024, Vol. 11 Issue 5, p665-669. 5p.

Record details

The prescription and monitoring of conventional synthetic disease-modifying anti-rheumatic drugs: British Society for Rheumatology guideline scope.

• Authors : Mercer, Louise; Abhishek, Abhishek; Kavirayani, Akhila

Subjects: ANTIRHEUMATIC agents; RHEUMATOLOGY; RHEUMATISM

• Source: Rheumatology Advances in Practice; 2024, Vol. 8 Issue 3, p1-5, 5p

Record details

Oral Methotrexate Treatment of Delayed-Onset Inflammatory Reactions to Dermal Fillers.

• Authors : Landau, Marina; Silikovich, Fernando; Fida, Monika

• Source: Aesthetic Surgery Journal Open Forum; 2024, Vol. 6, p1-7, 7p

Record details

Hepatotoxicity from high-dose methotrexate in primary central nervous system lymphoma.

• Authors : Zhang, Joy C; Stotts, Matthew J; Horton, Bethany

Subjects: CENTRAL nervous system; HEPATOTOXICOLOGY; METHOTREXATEUNIVERSITY of Virginia

• Source: Neuro-Oncology Practice; Jun2023, Vol. 10 Issue 3, p291-300, 10p

Record details

European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL).

• Authors : Hoang-Xuan, Khê; Deckert, Martina; Ferreri, Andrés J M

• Source: Neuro-Oncology; Jan2023, Vol. 25 Issue 1, p37-53, 17p

Record details

E POSTERS.

Subjects: RHEUMATOLOGY; JUVENILE idiopathic arthritis; CONFERENCES & conventionsAFRICA

• Source: Rheumatology; 2022 Supplement, Vol. 61, pii3-ii35, 114p

Record details

Mechanisms underlying DMARD inefficacy in difficult-to-treat rheumatoid arthritis: a narrative review with systematic literature search.

• Authors : Roodenrijs, Nadia M T; Welsing, Paco M J; Roon, Joël van

Subjects: RHEUMATOID arthritis treatment; DRUG efficacy; ONLINE information services

• Source: Rheumatology; Sep2022, Vol. 61 Issue 9, p3552-3566, 15p

Record details

Adverse effects related to methotrexate polyglutamate levels: adjudicated results from the cardiovascular inflammation reduction trial.

• Authors : Xu, Chang; Selhub, Jacob; Jacques, Paul

Subjects: GLUTAMIC acid; CONFIDENCE intervals; LIQUID chromatography

• Source: Rheumatology; Jun2021, Vol. 60 Issue 6, p2963-2968, 6p

Record details

Immunoglobulin D-kappa multiple myeloma in a patient with rheumatoid arthritis: a case report and review of the literature.

• Authors : Tokunaga, Tadahiro; Hashimoto, Hiroo; Yoshida, Yusuke

Subjects: IMMUNOGLOBULIN D; MULTIPLE myeloma; RHEUMATOID arthritis

• Source: Modern Rheumatology Case Reports; Jan2021, Vol. 5 Issue 1, p22-28, 7p

Record details

Comment on: Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials.

• Authors : Murray, Kieran E; Turk, Matthew A; Veale, Douglas J

Subjects: THERAPEUTIC use of folic acid; DRUG therapy for rheumatism; ANEMIA

• Source: Rheumatology; Oct2020, Vol. 59 Issue 10, pe74-e75, 2p

Record details